SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - LIGAND PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$696,613
+10.1%
9,4700.0%0.02%
+45.5%
Q4 2022$632,596
-48.5%
9,470
-33.6%
0.01%
-47.6%
Q3 2022$1,229,000
+127.6%
14,270
+197.3%
0.02%
+90.9%
Q1 2022$540,000–4,800–0.01%–
 Download
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders